Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Jan 28;17(1):e0263055. doi: 10.1371/journal.pone.0263055

Mood disorders in children following neonatal hypoxic-ischemic encephalopathy

María Álvarez-García 1, Isabel Cuellar-Flores 2, Purificación Sierra-García 3,, José Martínez-Orgado 2,‡,*
Editor: Thalia Fernandez4
PMCID: PMC8797213  PMID: 35089978

Abstract

Background

Few studies on the consequences following newborn hypoxic-ischemic encephalopathy (NHIE) assess the risk of mood disorders (MD), although these are prevalent after ischemic brain injury in adults.

Objective

To study the presence of MD in children survivors of NHIE.

Methods

14 children survivors of NHIE treated with hypothermia and without cerebral palsy and 15 healthy children without perinatal complications were studied aged three to six years for developmental status (Ages and Stages Questionnaire 3 [ASQ-3]) and for socio-emotional status (Preschool Symptom Self-Report [PRESS] and Child Behavior Checklist [CBCL] 1.5–5 tests). Maternal depression was assessed using Montgomery-Asberg Depression Rating Scale (MADRS). Socio-economic factors such as parental educational level or monthly income were also studied.

Results

NHIE children did not present delay but scored worse than healthy children for all ASQ3 items. NHIE children showed higher scores than healthy children for PRESS as well as for anxious/depressive symptoms and aggressive behavior items of CBCL. In addition, in three NHIE children the CBCL anxious/depressive symptoms item score exceeded the cutoff value for frank pathology (P = 0.04 vs healthy children). There were no differences in the other CBCL items as well as in maternal MADRS or parental educational level or monthly income. Neither ASQ3 scores nor MADRS score or socio-economic factors correlated with PRESS or CBCL scores.

Conclusions

In this exploratory study children survivors of NHIE showed increased risk of developing mood disturbances, in accordance with that reported for adults after brain ischemic insults. Considering the potential consequences, such a possibility warrants further research.

Introduction

Neonatal hypoxic-ischemic encephalopathy (NHIE) affects 1.5-3/1000 live newborns [1]. Despite the high impact on emotional and psychological wellbeing in infancy, most studies on the consequences following NHIE focused on motor and cognitive domains as well as on behavioral problems, mainly attention deficits and hyperactivity [2]. However, studies about the development of mood disorders (MD) in children surviving NHIE are scarce. This is striking taking into account that MD are a frequent complication of acute ischemic brain injury (IBI) in adults, which affect close to a third of those patients [3, 4]. Such disorders appear the following five years after the ischemic injury, peak three to five months post-insult, and consist mainly of depression but also anxiety, dysthymia, and adjustment disorders [3, 4]. The importance of such complications is stressed by the fact that MD following acute IBI in adults, in particular depression, are associated with increased mortality, worse quality of life and impaired physical and cognitive recovery in the short and long term [4, 5].

Reasons for the paucity of studies on the socio-emotional consequences of NHIE are multiple. There is considerable resistance to acknowledging that children may suffer MD or emotional psychopathology [6]. Assessment of MD in pre-school children is particularly difficult due to the intrinsic characteristics of this period [7, 8] The most worrying consequence of NHIE, cerebral palsy (CP), is associated with an increased presence of MD as in any chronic disabling condition leading to a significant loss of quality of life for patients and their parents [9]. Those emotional consequences of disability because of CP can mask the effects of NHIE by itself on development of MD when NHIE survivors developing CP are included in the study.

Psychopathology in children is often organized around three broad domains: internalizing, externalizing, and dysregulation symptoms [10]. One study in three-year-old children survivors of mild-to-moderate NHIE without CP reported increased anxiety and aggressive behavior [11]. However, children in that study did not receive hypothermia as a treatment for NHIE, which makes those results of limited value for current babies receiving hypothermia for moderate-to-severe NHIE as a standard of care [1]. A more recent study [12] reported increased anxiety/depression symptoms as well as sleep disorders in two-year-old children with minor neurologic symptoms after NHIE treated with hypothermia. However, that study does not compare NHIE children with healthy children but rather NHIE children with minor neurologic symptoms versus NHIE children without a neurologic symptom study [12].

The aim of this work was to study the presence of MD in children admitted as newborns to be treated with hypothermia for NHIE. We then compared that population with healthy children with no history of problems as newborns, and assessed those contextual factors that could potentially influence the development of such disorders.

Methods

The study, comparing the characteristics of neonatal HIE survivors with children of the same age without perinatal negative events, was approved by the Hospital’s Clinical Research Ethics Committee (December 2018, record 12.1/18, CI: 18/534-E). Families were invited to participate in the study. They were informed of the study’s general objective and procedure. All parents who agreed to participate signed the informed consent form.

Study population and sample selection

Children included in the study were infants born at more than 35 weeks of gestational age, admitted to the Hospital’s Neonatal Intensive Care Unit between January 2013 and December 2017 for consideration of hypothermia treatment because of moderate-to-severe NHIE. Severity of NHIE was classified following the modified Sarnat and Sarnat staging [13]. Another inclusion criteria was that the baby should have been included in our multi-disciplinary follow-up program at discharge. Exclusion criteria were death before discharge, major birth defects, no inclusion in hypothermia treatment, development of cerebral palsy during follow-up or parents refusing follow-up and/or with significant Spanish language limitations. In all babies from the study group a MRI scan was performed five to eight days after the hypoxic-ischemic event. MRI scan was repeated in all babies by the age of two to three years. By the time of the study, parents of selected patients were contacted by phone call to schedule a special visit to perform the assessment interview.

Once study patients were selected, babies > 35 weeks of gestational age with no noticeable perinatal complication, born during the same period and matched for gestational age, birth weight, sex and date of birth were identified in the clinical records. Parents were contacted by phone call to be invited to voluntarily attend a special visit to perform the assessment interview.

Assessment

At the age of three to six years, a special visit was scheduled, unique for the control group and in addition to the usual follow-up in the case of NHIE babies. During that visit, the assessment protocol was completed by children and by parents. The assessment interview was performed by two experienced clinical psychologists, who were not blinded to the experimental group.

Demographics

Educational level was scored as follows: 1 = no studies; 2 = primary education; 3 = secondary education; 4 = professional training; 5 = high school; 6: higher professional training; 7: university.

Income per month was scored as follows: 1 = no income; 2 = unemployment subsidy; 3 = €500–1000; 4 = €1000–1500; 5: €1500–2000; 6 = more than €2000.

Development

Parents answered the Ages and Stages Questionnaire 3 (ASQ-3) [14] to assess the child’s development in several domains (communication, fine and gross motor skills, problem solving and personal-social skills). ASQ3 can be used in children aged one month to six years and have a similar predictive value to the Bayley III test [12].

Emotional assessment

The socio-emotional status of children was assessed using two different approaches. Parents completed the Child Behavior Checklist (CBCL) for children aged one and a half to five years from the Achenbach System of Empirically Based Assessment ASEBA [15] to assess difficulties in several sets of behaviors (emotionally reactive, anxious/depressed, somatic complaints, withdrawn, sleep problems, attention problems, aggressive behavior, other problems) grouped into two broad bands of behavioral problems (Internalizing and Externalizing Problems). Children completed the Preschool Symptom Self-Report (PRESS), a pictorial instrument that assesses, with self-informed responses from identification with images, the presence of depression symptoms in preschool children [16].

Parents also answered the Montgomery-Asberg Depression Rating Scale (MADRS) [17] to assess the presence of depression symptomatology and its intensity.

Statistical analysis

Data distribution was assessed using the Shapiro-Wilks test and found to follow a non-parametric distribution. Therefore, data were compared using the Mann-Whitney-U for comparisons between two groups. Contingency tables were analyzed using X2. Data were shown as mean (95% CI) and analyzed with a statistical software package (GraphPad Prism 5; GraphPad Software, San Diego, CA, USA). A value of P<0.05 was considered statistically significant.

Results

Study population flowchart is shown in Fig 1. Eventually 14 NHIE and 15 healthy children were assessed age three to six years. Of the 14 NHIE children, 11 had a normal MRI scan five to eight days after birth, whereas three babies showed a small focal lesion in the temporal or parieto-occipital cortex (Fig 2). None of the newborns showed any damage in the Basal Ganglia, Hypothalamus, Hippocampus or frontal cortex. All NHIE children showed normal MRI scans age two to three years.

Fig 1. Study population.

Fig 1

Babies eligible for the study were admitted to the neonatal Intensive Care Unit for consideration of hypothermia treatment for moderate-to-severe hypoxic-ischemic encephalopathy. Healthy babies with no perinatal problems matched for gestational age, birth weight, sex, and date of birth were selected for the control group.

Fig 2. Representative MRI scans showing altered studies in two hypoxic-ischemic newborns.

Fig 2

In A, the MRI scan performed at postnatal day 5 in a female (39 weeks of gestational age) showed increased signal in both temporal lobes using Diffusion-Weighed Images; scan performed in the same patient aged 30 months showed no abnormalities (B). In C, the MRI scan performed at postnatal day 5 in a male (41 weeks of gestational age) showed linear hyperintensity in left insular subcortical area using T1-Weighed Images; scan performed in the same patient aged 26 months showed no abnormalities (D).

Sociodemographic and clinical profile

Control and NHIE groups were similar in gestational age, birth weight, sex distribution and age at assessment (Table 1). One baby from the NHIE group and two babies from the control group were born at 36 weeks of gestational age; the other were born at 37 weeks or more. Furthermore, socio-economic characteristics such as educational level or income per month were similar in both groups (Table 1). Children from both groups attended regular school at the time of the assessment interview. All children from the NHIE group were included by protocol in Early Intervention programs after discharge from the Intensive Care Unit.

Table 1. Demographic data of control group and NHIE group children.

Control (n = 15) NHIE (n = 14) P value
Age at study (months) 54.0 (47.5, 60.5) 46.0 (42.9, 56.5) 0.30
Gestational age (weeks) 39.0 (37.7, 39.9) 39.0 (37.7, 39.4) 0.48
Birth weight (g) 3210 (2817, 3558) 3040 (2912, 3520) 0.49
Male/female 11/4 10/4 0.91
Educational levela
    Mother 7.0 (5.7, 7.0) 7.0 (5.4, 7.1) 0.82
    Father 7.0 (6.1, 7.3) 7.0 (5.3, 7.3) 0.26
Income per monthb 6 (5.5, 6.1) 6 (4.9, 5.9) 0.09

Median (95% CI). Statistical analysis using the Mann-Whitney test.

NHIE: newborn hypoxic-ischemic encephalopathy.

Development

Children from the NHIE group showed lower scores for all ASQ3 test items than children from the control group (Table 2). However, although performance was worse, mean values of all ASQ3 items in NHIE children did not attain the cutoff value to define a “delay”, according to ASQ3 staging [14].

Table 2. Results from testing with the ASQ3.

Control (n = 15) NHIE (n = 14) P value
Communication skills 55 (51.1, 56.3) 45 (42.9, 52.0) 0.006
Gross motor skills 60 (57.8, 60.1) 55 (50.9, 57.66) 0.009
Fine motor skills 55 (53.6, 58.4) 47.5 (40.0, 53.5) 0.02
Problem solving 60 (57.4, 60.5) 57.5 (50.8, 58.4) 0.02
Personal-social 60 (51.9, 60.7) 50 (44.9, 53.6) 0.002

Median (95% CI). Statistical analysis using the Mann-Whitney test.

ASQ3: Ages and Stages Questionnaire-3.

NHIE: newborn hypoxic-ischemic encephalopathy.

Emotional assessment

The self-informed PRESS responses indicated that NHIE children had a greater presence of depression symptoms than children from the control group (PRESS score 0.00 [-0-18, 1.78] vs 2.00 [1.26, 4.42] points, median [95% CI] for the control and NHIE group, respectively, Mann-Whitney P = 0.01).

The CBCL test did not reveal differences between NHIE and control children with the exception of two items: anxious/depressed symptoms, among internalizing problems, and aggressive behavior, among externalizing problems, in which NHIE children showed a higher score than control group children (Table 3). Moreover, after considering the accepted cutoff values for CBCL staging [15] three out of the 14 NHIE children versus none of the control group children obtained such a score in the anxious/depressed symptoms item as to be considered of clinical concern (X2 = 3.88, P = 0.04). In the case of aggressive behavior, two NHIE children and no control group children scored at values considered of clinical concern (X2 = 2.30, P = 0.12)

Table 3. Results from testing with the CBCL 1.5–5.

Control (n = 15) NHIE (n = 14) P value
Internalizing
    Emotionally reactive 2.00 (0.76, 2.70) 1.50 (0.58, 5.56) 0.43
    Anxious/depressive 1.00 (0.69, 2.76) 2.00 (1.69, 5.46) 0.03
    Somatic complaints 1.00 (0.64, 2.01) 2.00 (0.75, 2.96) 0.28
    Withdrawn 1.00 (0.64, 2.01) 0.00 (0.09, 3.34) 0.19
Externalizing
    Attention 2.00 (1.40, 3.39) 3.00 (1.68, 4.03) 0.33
    Aggressive behavior 5.00 (4.14, 9.58) 10.50 (8.27, 16.73) 0.004
Sleep problems 2.00 (0.87, 3.38) 2.50 (1.28, 3.71) 0.31
Other problems 6.00 (4.14, 8.78) 7.00 (4.96, 14.03) 0.23

Median (95% CI). Statistical analysis using the Mann-Whitney test.

CBCL 1.5–5: Child Behavior Checklist 1.5–5.

NHIE: newborn hypoxic-ischemic encephalopathy.

There were no differences in the score obtained in the depression scale (MADRS) between mothers from NHIE or control group children (MADRS score: 2.00 [1.42, 3.89] vs 4.00 [3.02, 10.20] points, median [95% CI] for control and NHIE, respectively, Mann-Whitney P = 0.23).

Factors associated with psychological symptoms in children diagnosed with HIE

After considering the items showing a poorer score in NHIE than in the control group children, PRESS and anxious/depressed symptoms and aggressive behavior in CBCL, no correlation was found between those items and child neurologic impairment, as assessed using ASQ3, maternal depression as assessed using MADRS, or socio-economic characteristics such as educational level or monthly income (Table 4).

Table 4. Correlation between developmental assessment and contextual factors and items of mood disturbances in NHIE group children.

PRESS CBCL Anxious/depressed CBCL Aggressive behavior
R 95% CI P R 95% CI P R 95% CI P
ASQ3
    Communication -0.19 -0.68, 0.41 0.51 0.10 -0.46, 0.61 0.72 -0.05 -0.54, 0.53 0.98
    Gross motor -0.30 -0.74, 0.31 0.31 0.10 -0.46, 0.51 0.71 0.07 -0.48, 0.59 0.79
    Fine motor -0.26 -0.72, 0.35 0.37 0.13 -0.44, 0.63 0.64 -0.72 -0.59, 0.49 0.80
    Problem solving 0.07 -0.51, 0.61 0.81 -0.09 -0.60, 0.47 0.75 -0.17 -0.65, 0.40 0.54
    Personal-Social 0.04 -0.56, 0.56 0.98 -0.14 -0.63, 0.43 0.61 -0,52 -0.82, 0.09 0.08
MADRS 0.32 -0.29, 0.75 0.28 0.01 -0.54, 0.55 0.99 -0.10 -0.61, 0.46 0.72
Education level -0.56 -0.89, 0.08 0.08 0.25 -0.37, 0.69 0.38 0.17 -0.41, 0.65 0.56
Monthly Income -0.47 -0.82, 0.11 0.09 -0.03 -0.57, 0.56 0.77 -0.31 -0.74, 0.43 0.29

Statistical analysis using Spearman’s correlation.

ASQ3: Ages and Stages Questionnaire-3.

CBCL 1.5–5: Child Behavior Checklist 1.5–5.

MADRS: Montgomery-Asberg Depression Rating Scale.

NHIE: newborn hypoxic-ischemic encephalopathy.

PRESS: Preschool Symptom Self-Report.

Discussion

This study alerts about an increased risk of MD, in particular of anxious/depressive nature, as observed in three-to-six-year old children survivors of moderate-to-severe NHIE without CP. This is the first study in which indicators of MD have been studied in children treated with the current standard of care for NHIE, hypothermia, and compared to healthy children with no history of neonatal complications. Increased incidence of MD in NHIE children would link NHIE outcome with that of acute IBI in adults, in which the incidence of MD, in particular depression and anxiety, is dramatically increased [3, 4].

Cognitive and motor repercussions of NHIE in children have been extensively studied [2, 18]. Cognitive and behavioral impairment, such as difficulties in attention, language and executive functions, are commonly observed in children with NHIE without CP [2]. However, very few studies have included the assessment of socio-emotional disturbances in that population [11, 12]. Assessing MD in pre-school children is difficult because cognitive characteristics and language development at this age lead to a different expression of psychopathology compared to adults [7]. Nevertheless, nowadays there is a consensus regarding the existence and symptomatology of childhood depression [8]. Depressed mood and aggressive behavior are seen as different forms in which children could express depressive symptoms: the Diagnostic and Statistical Manual of Mental Disorders (DSM 5) specifies that, in the case of children, depressive symptoms are usually expressed as irritable mood rather than or in addition to sadness [8].

In this study we used two different scales and different information sources to assess MD and other psychopathologies. The CBCL is one of the most used and well-validated instruments. It is also used to screen MD in children [19], and shows an adequate capacity to detect psychological disorders [20]. In particular CBCL 1.5–5 have proved to be an effective diagnostic tool for children at an age similar to that of the children in our study [21]. It is completed by parents, which enables obtaining comprehensive information about three broad domains: internalizing, externalizing and dysregulation symptoms in which the psychopathology is organized [10]. The other scale, the PRESS, enables obtaining direct information from the children themselves [16], which can facilitate access to internalizing symptoms. Difficulty in accessing these kinds of symptoms from external observation could lead to their underestimation, as compared to externalizing symptoms [16].

Our study is the first to show that survivors of NHIE without CP, even after having been treated with hypothermia, have increased presence of anxiety/depression symptoms, as assessed by two different scales -PRESS and CBCL- as well as aggressive behavior more frequently than healthy children. Previous studies exploring those items detect only increased aggressivity in NHIE survivors with no treatment with hypothermia [11] or only anxiety/depression symptoms in NHIE survivors treated with hypothermia [12]. Moreover, those studies do not compare NHIE survivors with a normal population but rather compare two subgroups of NHIE survivors, the subgroup with minor or moderate and the other with no neurologic symptoms [11, 12]. Instead of comparing two subpopulations of NHIE children we compared the results of NHIE children with those of healthy children and this likely makes our analysis more powerful. We must be cautious due to the small sample size; but it is worth noting that the number of children from the NHIE group with clear symptoms of depression according to the CBCL -three out of 14- indicates a proportion of depressed children after NHIE similar to the proportion reported for adults after acute IBI [3, 22].

Different conditions could justify the development of MD in children after NHIE. The onset of depressive symptoms in children developing CP after NHIE has been attributed to brain damage and cognitive impairment but not necessarily to the motor disability [9]. In our study, NHIE survivors did not develop CP. In addition, although children from the NHIE group showed worse cognitive and motor performance as observed using the ASQ-3, none showed a frank delay in any item. It is well known that careful examination can unveil subtle worse cognitive and motor performance even in NHIE survivors with no apparent functional repercussion [18]. It was noteworthy that no relationship was revealed in our study between cognitive or motor performance scores and PRESS score or anxious/depressive symptom or aggressive behavior scores for the CBCL. This makes a significant influence of the feeling of living with poor motor and/or cognitive performance on the development of MD unlikely.

Family socio-economic status has a remarkable impact on the onset of motor and cognition development impairment as well as behavioral disturbances after NHIE, in particular when the developmental impairment is mild [23]. In our study, however, educational background and monthly income were similar in families from NHIE or healthy children, and no relationship was found between those contextual factors and anxiety/depression symptoms in either the CBCL or PRESS score.

The emotional development of children may also be affected by the parents’ emotional status. Thus, maternal depression is linked to higher levels of psychopathology and negative affect and behavior in children [24]. In our study MADRS score, which assesses the onset of symptoms of depression in mothers, was similar in mothers of NHIE or of healthy children. Furthermore, no relationship was detected between maternal MADRS score and anxiety/depression symptoms in either the CBCL or PRESS score.

Altogether, these results indicate that contextual factors such as the appearance of non-severe physical disability, family socio-economic status or maternal depression were not major determinants of the onset of MD in survivors of NHIE. Similarly, external factors such as mental distress due to disability or socio-economic factors are not major determinants of the appearance of MD after acute IBI in adults [5, 25]. Increased evidence supports a neurochemical basis for MD after acute IBI in adults [4, 26]. The most popular hypothesis is that excitotoxicity and inflammation-induced damage of monoaminergic pathways results in reduced synthesis of serotonin and norepinephrine, leading to development of MD [4, 5, 26]. Thus, location of the IBI has a major impact on the risk of subsequent development of MD in adults [3]. Interestingly, in our study all except three HIE newborns had normal MRI scans in the neonatal period; the three abnormal MRI scans consisted of small focal ischemic areas in the parietal cortex, far from the usual location of brain lesions in adults developing MD after IBI [3]. Moreover, all the children in our study had normal MRI scans by the age of two to three years. Immature brain is particularly sensitive to excitotoxicity and inflammation [27]. Hence, hypoxic-ischemic insult might result in monoaminergic pathway damage even in the absence of a visible lesion. However, this remains speculative.

Whereas the comparison of children with NHIE treated with the current standard of care with healthy children is a clear strength of our work, the small sample size of study groups is a limitation. However, the NHIE group size in our work (n = 14) is similar to that of previous studies with NHIE survivors with non-severe neurologic sequelae regardless of cooling (n = 10) [12] or no cooling (n = 17) [11]. Furthermore, NHIE children in our studies attained similar CBCL scores than those of the NHIE subgroup children with minor neurologic sequelae in the study most comparable to ours—the study of children cooled because of NHIE [12]. This similarity adds some robustness to our own results.

The possibility of increased risk of MD as a consequence of NHIE is of paramount importance. In adults, MD after IBI not only increases mortality and impairs quality of life, but clearly has a negative impact on patients’ ability to engage in rehabilitation therapies, which jeopardizes their physical and cognitive recovery [4, 26]. Whether or not the onset of MD after NHIE could interfere with effective rehabilitation and healthy development in those children warrants further research.

A limitation of our study could be that researchers were not blind to the experimental group since NHIE children were assessed at the follow-up clinical whereas healthy children attended a special visit. However, the different measures collected in our study were self- completed by parents (ASQ-3, MDRS and CBCL) or children (PRESS). Therefore, since scoring did not need the intervention of the evaluator, it is unlikely that a researcher bias could have affected the results.

Conclusions

This exploratory work indicates that infants surviving after NHIE treated with hypothermia with non-severe neurologic symptoms and no evidence of brain damage in the MRI, show increased risk of MD aged three to six when compared with healthy children with a normal neonatal period. These disorders were not related to physical and cognitive developmental scores, family socio-economic status or presence of maternal depression. The relevance of the theoretical impact such disorders could have on children’s quality of life and chance of a full recovery justify inclusion of its routine assessment in the follow-up of these children as well as commencing further studies with a larger population.

Supporting information

S1 File

(PDF)

Acknowledgments

We thank the children and parents who generously and enthusiastically participated in this study. We are also grateful to Jason Willis-Lee for scientific writing assistance during preparation of the final manuscript.

Data Availability

Deidentified individual participant data (including data dictionaries) will be made available, in addition to study protocols, the statistical analysis plan, and the informed consent form. Data will be made available upon publication to researchers who provide a methodologically sound proposal for use in achieving the approved proposal’s goals. Proposals should be submitted to the corresponding author as well as to the Hospital Clínico San Carlos' Clinical Research Ethics Committee (ceic.hcsc@salud.madrid.org).

Funding Statement

This project received funds from the program ECL.NEONAT from the Biomedical Research Foundation of the Hospital Clinico San Carlos. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Natarajan G, Pappas A, Shankaran S. Outcomes in childhood following therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy (HIE). Semin Perinatol. 2016;40: 549–555. doi: 10.1053/j.semperi.2016.09.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Schreglmann M, Ground A, Vollmer B, Johnson MJ. Systematic review: long-term cognitive and behavioural outcomes of neonatal hypoxic–ischaemic encephalopathy in children without cerebral palsy. Acta Paediatrica, International Journal of Paediatrics. Blackwell Publishing Ltd; 2020. pp. 20–30. doi: 10.1111/apa.14821 [DOI] [PubMed] [Google Scholar]
  • 3.Mitchell AJ, Sheth B, Gill J, Yadegarfar M, Stubbs B, Yadegarfar M, et al. Prevalence and predictors of post-stroke mood disorders: A meta-analysis and meta-regression of depression, anxiety and adjustment disorder. Gen Hosp Psychiatry. 2017;47: 48–60. doi: 10.1016/j.genhosppsych.2017.04.001 [DOI] [PubMed] [Google Scholar]
  • 4.Wang Z, Shi Y, Liu F, Jia N, Gao J, Pang X, et al. Diversiform etiologies for poststroke depression. Frontiers in Psychiatry. Frontiers Media S.A.; 2019. doi: 10.3389/fpsyt.2018.00761 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Loubinoux I, Kronenberg G, Endres M, Schumann-Bard P, Freret T, Filipkowski RK, et al. Post-stroke depression: Mechanisms, translation and therapy. J Cell Mol Med. 2012;16: 1961–1969. doi: 10.1111/j.1582-4934.2012.01555.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Emde RN. Next steps in emotional availability research. Attach Hum Dev. 2000;2: 242–248. doi: 10.1080/14616730050085590 [DOI] [PubMed] [Google Scholar]
  • 7.Egger HL, Angold A. Common emotional and behavioral disorders in preschool children: Presentation, nosology, and epidemiology. Journal of Child Psychology and Psychiatry and Allied Disciplines. J Child Psychol Psychiatry; 2006. pp. 313–337. doi: 10.1111/j.1469-7610.2006.01618.x [DOI] [PubMed] [Google Scholar]
  • 8.Powell A, Ocean S, Stanick C. Depressive disorders. In: Goldstein S, DeVries M, editors. Handbook of DSM-5 disorders in children and adolescents. Springer International Publishing AG; 2017. pp. 151–174. [Google Scholar]
  • 9.Rackauskaite G, Bilenberg N, Bech BH, Uldall P, Østergaard JR. Screening for psychopathology in a national cohort of 8- to 15-year-old children with cerebral palsy. Res Dev Disabil. 2016;49–50: 171–180. doi: 10.1016/j.ridd.2015.11.019 [DOI] [PubMed] [Google Scholar]
  • 10.Zeanah CH. Disturbances of attachment in young children adopted from institutions. J Dev Behav Pediatr. 2000;21: 230–236. Available: https://pubmed.ncbi.nlm.nih.gov/10883884/ [PubMed] [Google Scholar]
  • 11.Hayes BC, Doherty E, Grehan A, Madigan C, McGarvey C, Mulvany S, et al. Neurodevelopmental outcome in survivors of hypoxic ischemic encephalopathy without cerebral palsy. Eur J Pediatr. 2018;177: 19–32. doi: 10.1007/s00431-017-3028-3 [DOI] [PubMed] [Google Scholar]
  • 12.Edmonds CJ, Helps SK, Hart D, Zatorska A, Gupta N, Cianfaglione R, et al. Minor neurological signs and behavioural function at age 2 years in neonatal hypoxic ischaemic encephalopathy (HIE). Eur J Paediatr Neurol. 2020;27: 78–85. doi: 10.1016/j.ejpn.2020.04.003 [DOI] [PubMed] [Google Scholar]
  • 13.Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33: 696–705. Available: http://www.ncbi.nlm.nih.gov/pubmed/987769 doi: 10.1001/archneur.1976.00500100030012 [DOI] [PubMed] [Google Scholar]
  • 14.Squires J, Potter L, Bricker D. The ASQ user’s guide. Edition in. Paul H. Brookes Publishing Co; 2009. [Google Scholar]
  • 15.Achenbach TL, Rescorla LA. Manual for the ASEBA School-Age Forms & Profiles. University of Vermont, Research Center for Children, Youth, & Families.; 2001. [Google Scholar]
  • 16.Martini DR, Strayhorn JM, Puig-Antich J. A Symptom Self-Report Measure for Preschool Children. J Am Acad Child Adolesc Psychiatry. 1990;29: 594–600. doi: 10.1097/00004583-199007000-00013 [DOI] [PubMed] [Google Scholar]
  • 17.Lobo A, Chamorro L, Luque A, Dal-Ré R, Badia X, Baró E, et al. Validation of the Spanish versions of the Montgomery-Asberg Depression and Hamilton Anxiety Rating Scales. Med Clin (Barc). 2002;118: 493–499. doi: 10.1016/s0025-7753(02)72429-9 [DOI] [PubMed] [Google Scholar]
  • 18.Conway JM, Walsh BH, Boylan GB, Murray DM. Mild hypoxic ischaemic encephalopathy and long term neurodevelopmental outcome—A systematic review. Early Hum Dev. 2018;120: 80–87. doi: 10.1016/j.earlhumdev.2018.02.007 [DOI] [PubMed] [Google Scholar]
  • 19.de la Osa N, Granero R, Trepat E, Domenech JM, Ezpeleta L. The discriminative capacity of CBCL/1½-5-DSM5 scales to identify disruptive and internalizing disorders in preschool children. Eur Child Adolesc Psychiatry. 2016;25: 17–23. doi: 10.1007/s00787-015-0694-4 [DOI] [PubMed] [Google Scholar]
  • 20.Kim JY, Ha EH. Cluster Analysis of the Child Behavior Checklist 1.5–5 for Preschool Children Diagnosed With a Mental Disorder. Psychol Rep. 2020;123: 1403–1424. doi: 10.1177/0033294119844980 [DOI] [PubMed] [Google Scholar]
  • 21.Buchmüller T, Lembcke H, Busch J, Kumsta R, Leyendecker B. Exploring mental health status and syndrome patterns among young refugee children in Germany. Front Psychiatry. 2018;9. doi: 10.3389/fpsyt.2018.00009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wang EY, Meyer C, Graham GD, Whooley MA. Evaluating Screening Tests for Depression in Post-Stroke Older Adults. J Geriatr Psychiatry Neurol. 2018;31: 129–135. doi: 10.1177/0891988718778791 [DOI] [PubMed] [Google Scholar]
  • 23.Miller SP, Newton N, Ferriero DM, Partridge JC, Glidden D V., Barnwell A, et al. Predictors of 30-month outcome after perinatal depression: Role of proton MRS and socioeconomic factors. Pediatr Res. 2002;52: 71–77. doi: 10.1203/00006450-200207000-00014 [DOI] [PubMed] [Google Scholar]
  • 24.Koutra K, Roumeliotaki T, Kyriklaki A, Kampouri M, Sarri K, Vassilaki M, et al. Maternal depression and personality traits in association with child neuropsychological and behavioral development in preschool years: Mother-child cohort (Rhea Study) in Crete, Greece. J Affect Disord. 2017;217: 89–98. doi: 10.1016/j.jad.2017.04.002 [DOI] [PubMed] [Google Scholar]
  • 25.Backhouse E V., McHutchison CA, Cvoro V, Shenkin SD, Wardlaw JM. Cognitive ability, education and socioeconomic status in childhood and risk of post-stroke depression in later life: A systematic review and meta-analysis. PLoS One. 2018;13: 1–15. doi: 10.1371/journal.pone.0200525 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Villa RF, Ferrari F, Moretti A. Post-stroke depression: Mechanisms and pharmacological treatment. Pharmacology and Therapeutics. Elsevier Inc.; 2018. pp. 131–144. doi: 10.1016/j.pharmthera.2017.11.005 [DOI] [PubMed] [Google Scholar]
  • 27.Johnston M V., Fatemi A, Wilson MA, Northington F. Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol. 2011;10: 372–382. doi: 10.1016/S1474-4422(11)70016-3 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Thalia Fernandez

1 Nov 2021

PONE-D-21-13777MOOD DISORDERS IN CHILDREN FOLLOWING NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHYPLOS ONE

Dear Dr. Martínez-Orgado,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The reviewers agree that it is a professionally written article that adds new knowledge; therefore, they recommend its publication. However, they do make several suggestions that must be followed.

Additionally, in the statistical analysis, I would like the effect size to be included.

Please submit your revised manuscript by December 16, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Thalia Fernandez, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript is professionally written. It describes the possible presence of Mood Disorders (MD) in a group of 14 children between 3- and six-year-old that at birth present Hypoxic Ischemic Encepalopathy (HIE) from moderate to severe (the scale values of Sarnat and Sarnat scores are not described) that were treated with hypothermia and without cerebral palsy and 15 healthy children without perinatal complications matched by gestational age, socioeconomic status, parental educational level, or monthly income. Infants had 35 weeks of gestational age or more. I will recommend the authors to include more clearly the number of preterm and term infants in the study, since the mean age in both groups was 38 weeks.

The study used well known questionnaires to the parents, the Ages and Stages Questionnaire 3 (ASQ-3), the Child Behavior Checklist (CBCL) for children aged one and a half to five years, and the Montgomery-Asberg Depression Rating Scale (MADRS). Children completed the Preschool Symptom Self-Report (PRESS), a 143 pictorial instrument that assesses, with self-informed responses from identification with 144 images, the presence of depression symptoms in preschool children.

Unfortunately, in the abstract only the acronyms of the tests are used. My recommendation is to use the complete title of the tests also in the abstract. This is mandatory.

Magnetic Resonance Images (MRI) were obtained from the children early after birth and at the age of two to three years. Authors only described the results of the images, but not include any figure. I think that the presentation of the images of the child with a lesion at birth and that was normal after 3 years will be welcome. The authors only describe MRI studies of the HIE group. To have a perfect mismatch with the HIE children, studies of the healthy children should be also included. It has been shown by MRI (Rutherford et al., 2010) that hypothermia treatment of infants with HIE decreases brain injury tissues, therefore should be interesting to know the MRI results of the control group. In case of preterm infants frequent MRI abnormalities have been described (Volpe, J in 2011, 2019; Woodward et al. 2012; and Harmony, 2021).

Conclusion: I recommend the authors to follow my suggestions.

Reviewer #2: Dear Editor and the authors,

Thank you for the opportunity to review the report about mood disorders in children with hypoxic-ischemic encephalopathy (HIE). The report is well written and worth publication, even it is a descriptive study because of the paucity of knowledge about emotional developments of infants after neonatal HIE. It adds new knowledge and is worth publication. However, there are some limitations of study, which have not been discussed. I will specify it below.

First, I will address the statistical analysis and presentation of the results. The authors have chosen the right method for the analyses (Mann-Whitney U test) because of skewed distribution of data. Therefore, results should be presented by medians instead of means.

The study was well planned, with two different sources of data regarding mood disorders (CBCL and PRESS) and a control group. I will also commend the authors for including the most important environmental factors (education level, income and parental depressive symptoms). Unfortunately, the assessors were not blinded. I fully understand that it is difficult to blind the assessors in a clinical setting, but I really miss discussion how not-blinded evaluation of the outcome affects the results.

Line 69-71. The authors state that emotional consequences of disability of CP can mask the effects of NHIE by itself. I totally agree. Later, when the authors cite the same study in the discussion, Line 281, they interpret results differently than the authors of the cited study. Rackauskaite et al. wrote “the high prevalence of psychopathology in children with CP may be due to brain impairment or cognitive disability and not to the motor disability itself”. Please, correct it.

Line 160-164 presents data from the Figure 1. There is no need for repetition.

Line 182/ Table 1. There is a difference of 6 months between the mean age of control and NHIE. Emotional development is quite fast between the age of 4½ and 4 years. Please, discuss if that can influence your results, even the ages are not statistically significant.

Line 238 is difficult to read. Please, rephrase.

Line 270-275 repeats information from the introduction.

Line 332-334. Handicap is a strong word in the context of HNIE. I suggest to reword “could be a handicap” by using a verb like “could disturb” or “interfere with”.

Line 341-342. Your data does not support the statement, that MD were not related to the severity of handicap. All children (HNIE and controls) had a normal motor and cognitive function, thereby no handicap.

I hope my suggestions will help the authors to improve their report.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Thalía Harmony

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Jan 28;17(1):e0263055. doi: 10.1371/journal.pone.0263055.r002

Author response to Decision Letter 0


18 Nov 2021

PONE-D-21-13777

Answers to Reviewer #1:

We wish to thank the Reviewer because his/her comments have greatly improved the quality of the manuscript.

Comments:

- I will recommend the authors to include more clearly the number of preterm and term infants in the study, since the mean age in both groups was 38 weeks.

o This has been included in the revised manuscript (lines 194-195). Since the original statement was confusing -all babies were of more than 35 weeks of gestational age-, it has been rewritten (line 107).

- My recommendation is to use the complete title of the tests also in the abstract.

o Complete title of tests have been included in the Abstract

- Magnetic Resonance Images (MRI) were obtained from the children early after birth and at the age of two to three years. Authors only described the results of the images, but not include any figure. I think that the presentation of the images of the child with a lesion at birth and that was normal after 3 years will be welcome. The authors only describe MRI studies of the HIE group. To have a perfect mismatch with the HIE children, studies of the healthy children should be also included. It has been shown by MRI (Rutherford et al., 2010) that hypothermia treatment of infants with HIE decreases brain injury tissues, therefore should be interesting to know the MRI results of the control group. In case of preterm infants frequent MRI abnormalities have been described (Volpe, J in 2011, 2019; Woodward et al. 2012; and Harmony, 2021).

o Representative examples of abnormal MRI in NHIE newborns with the correspondent normal scan when aged 2-3 years have been included in the revised version of the manuscript (Figure 2) (lines 182-189).

o The aim of the present work was focused on the study of Mood Disorders in the hypoxic-ischemic babies. The aim of presenting the MRI studies was to explore the possibility that mood disorders were related to the presence of damage in specific brain regions, which was not the case. Our work was not designed to explore the effects of hypothermia on hypoxic-ischemic brain damage as assessed by MRI, which has been extensively studied already, as the Reviewer stated. That is why the Ethical Committee did not approve to perform MRTI studies on healthy babies and children, who should have been exposed to sedation for the MRI study to be performed.

o MRI abnormalities are present mostly in very preterm infants (under 32 weeks of gestational age), as described in the bibliography cited by the Reviewer. Thus, the American Association of Neurology recommends since 2004 that routine MRI studies were performed only in very preterm infants or in those newborns at high neurological risk (Ment L et al, 2004). In our case, the only baby born at 36 weeks of gestational age in the NHIE group showed no abnormalities at the MRI studies.

PONE-D-21-13777

Answers to Reviewer #2:

We wish to thank the Reviewer because his/her comments have greatly improved the quality of the manuscript.

Comments:

- Results should be presented by medians instead of means

o All results have been presented as medians in tables and text in the revised manuscript

- I fully understand that it is difficult to blind the assessors in a clinical setting, but I really miss discussion how not-blinded evaluation of the outcome affects the results.

o The reviewer points out a very relevant aspect of clinical research. Having into account that NHIE children were assessed at the follow-up clinical whereas healthy children attended a special visit, blinding was impossible. However, the different measures collected in our study were either completed by parents or children (therefore without the intervention of the evaluator) or are highly structured and, again, do not require the interpretation of the researcher. Thus, Ages and Stages Questionnaire 3 (ASQ-3) and Child Behavior Checklist (CBCL) are questionnaires answered by parents, whereas the Preschool Symptom Self-Report (PRESS) scores as “present” or “absent” the answers of the child to a series of drawings. The Montgomery-Asberg Depression Rating Scale (MADRS) is a self-reported questionnaire. Therefore, researcher’s knowledge of about the experimental group is unlikely to interfere with the score since this was independent from the researcher’s opinion. This, lack of blinding is usual in this kind of studies (please see refs. 11 and 12 of the manuscript). This has been included in the Discussion (lines 441-447).

- Line 69-71. The authors state that emotional consequences of disability of CP can mask the effects of NHIE by itself. I totally agree. Later, when the authors cite the same study in the discussion, Line 287, they interpret results differently than the authors of the cited study. Rackauskaite et al. wrote “the high prevalence of psychopathology in children with CP may be due to brain impairment or cognitive disability and not to the motor disability itself”. Please, correct it.

o This has been corrected in the manuscript (lines 386-387).

- Line 160-164 presents data from the Figure 1. There is no need for repetition.

o This has been so corrected in the revised version of the manuscript (line 170)

- Line 182/ Table 1. There is a difference of 6 months between the mean age of control and NHIE. Emotional development is quite fast between the age of 4½ and 4 years. Please, discuss if that can influence your results, even the ages are not statistically significant.

o Besides the lack of statistical difference respecting the age at evaluation, age rank in both populations was very similar. In addition, CBCL 1.5-5 applies the same questionnaire for children between 1.5 and 5 years of age, assuming that responses between those boundaries are not affected by age (please see ref. 15 of the manuscript). In the case of ASQ-3 and PRESS, these are standardized tests, i.e., normalized for age. Therefore, the influence of the age difference in the results of our study is unlikely. In fact, even broader age ranks can be found in studies similar to ours (please see refs 11 and 12 of the manuscript).

- Line 238 is difficult to read. Please, rephrase.

o The line has been rephrased in the revised version of the manuscript (lines 338-339)

- Line 270-275 repeats information from the introduction.

o Repeated information has been removed from the Introduction in the revised version of the manuscript (line 87).

- Line 332-334. Handicap is a strong word in the context of HNIE. I suggest to reword “could be a handicap” by using a verb like “could disturb” or “interfere with”.

o This has been so reworded in the revised version of the manuscript (line 439)

- Line 341-342. Your data does not support the statement, that MD were not related to the severity of handicap. All children (HNIE and controls) had a normal motor and cognitive function, thereby no handicap.

o A more appropriate statement has been included in the revised version of the manuscript (lines 454-455)

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Thalia Fernandez

12 Jan 2022

MOOD DISORDERS IN CHILDREN FOLLOWING NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY

PONE-D-21-13777R1

Dear Dr. Martinez-Orgado,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Thalia Fernandez, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Thalia Fernandez

20 Jan 2022

PONE-D-21-13777R1

Mood Disorders in Children following Neonatal Hypoxic-Ischemic Encephalopathy

Dear Dr. Martínez-Orgado:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Thalia Fernandez

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (PDF)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    Deidentified individual participant data (including data dictionaries) will be made available, in addition to study protocols, the statistical analysis plan, and the informed consent form. Data will be made available upon publication to researchers who provide a methodologically sound proposal for use in achieving the approved proposal’s goals. Proposals should be submitted to the corresponding author as well as to the Hospital Clínico San Carlos' Clinical Research Ethics Committee (ceic.hcsc@salud.madrid.org).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES